Editorial on this Article from Phase I Study of Eribulin Mesylate Administered Once Every 21 Days in Patients with Advanced Solid Tumors
收藏NIAID Data Ecosystem2026-05-16 收录
下载链接：
https://figshare.com/articles/dataset/Editorial_on_this_Article_from_Phase_I_Study_of_Eribulin_Mesylate_Administered_Once_Every_21_Days_in_Patients_with_Advanced_Solid_Tumors/22440303
下载链接
链接失效反馈官方服务：
资源简介：
Editorial on this Article from Phase I Study of Eribulin Mesylate Administered Once Every 21 Days in Patients with Advanced Solid Tumors
创建时间：
2009-06-15
